Member Info for EarlofAim

maybe the fag packet should have @CizzlePlc tests ads, so smokers can take a test each year, lol.

you cracked me up lolz

typo error

very good summary of What's going on with Simec

bust? 30 more likely, Administration then another company will pick it up for £1, like Debenhams, Flybe, etc.....

all those think it's cheap, it's not cheap, it's going bust,

according to the last accounts I found (unaudited!- a massive danger sign!!!) the company is running at an annual loss of ~£24 mill ie the £ 2mill will keep them afloat for 1 month and yet they cite a date of this time next year to get a turbine in to the water (those of you more familiar can no doubt calculate how long it has been ashore) . How on earth are they going to keep going beyond next month let alone into next year?
Third, the elephant in the room is still there, a near defunct company with no liquidity holds a controlling interest in the stock , tho' the good(?) news is that that holding is essentially worthless.
As is always the case the viability of a company depends far more on cash than concepts and SAE sadly is desperately (IMV terminally) short of the former.

very good summary of What's going on with Simec

bust? 30 more likely, Administration then another company will pick it up for £1, like Debenhams, Flybe, etc.....

all those think it's cheap, it's not cheap, it's going bust,

according to the last accounts I found (unaudited!- a massive danger sign!!!) the company is running at an annual loss of ~£24 mill ie the £ 2mill will keep them afloat for 1 month and yet they cite a date of this time next year to get a turbine in to the water (those of you more familiar can no doubt calculate how long it has been ashore) . How on earth are they going to keep going beyond next month let alone into next year?
Third, the elephant in the room is still there, a near defunct company with no liquidity holds a controlling interest in the stock , tho' the good(?) news is that that holding is essentially worthless.
As is always the case the viability of a company depends far more on cash than concepts and SAE sadly is desperately (IMV terminally) short of the former.

Early diagnosis can make a huge difference in outcomes for lung cancer patients, and screening is particularly important for patients who are considered high-risk. But new data show that these patients are largely unaware of their screening options—and even those who are aware of them aren’t necessarily planning to pursue them.

More than half of current smokers—54%—know little or nothing about lung

https://www.fiercepharma.com/sponsored/high-risk-lung-cancer-patients-arent-getting-screened-survey-shows-what-can-industry-do

investing without knowledge of the debt can be very risky.
Simec will be deploying turbine under water next year......

in the meantime what will happen to their Debt obligations??

Just because Simec took the initiative to deploy turbines, who will fulfill their debt obligations?

are Simec going to stop Employers salaries?

a business without capital to fund the outgoings will go bust.

£50M debt is not like your typical life AIM gold exploration company, Simec needs to address the debt, then this can be investable, or else its just a pure gamble.

at least on oil or gold exploration investors knows what is expected.

GLA

Schalfenplanet thanks

hat's fantastic
"the health Secretary did mention that he was looking for some kind of detection in this subject"

China deal is good, I also think NHS deal would generate tremendous growth because currently there's no Early Lung Cancer detection available in the UK or in the NHS.

Cizzle-Biotech could monopolies UK NHS market.

potential is huge

3 February 2022

Cizzle Biotechnology Holdings Plc



("Cizzle Biotechnology" or the "Company")



Royalty Strategic Alliance for Early Lung Cancer Detection in China



Cizzle Biotechnology, the UK based diagnostics developer, is pleased to announce that following the signing of a Memorandum of Understanding ("MOU") with the International Co-Innovation Centre for Advanced Medical Technology ("iCCAMT") and Shenzhen Intelliphecy Life Technologies Co., Ltd. ("Intelliphecy"), announced on 25 November 2021, a full commercial agreement has now been executed to develop and market the Company's proprietary early lung cancer diagnostic tests in China (the "Agreement").



Highlights



· Commercial agreement reached with iCCAMT and Intelliphecy

· iCCAMT backers include German Medical Valley, Robert Bosch GmbH and Sinopharm Group

· iCCAMT and Intelliphecy to fund all activities in China, including development, clinical trials, manufacture and distribution

· 10% royalty for the Company over all sales of products and services using CIZ1B in China

· Initial pilot of 300 patients planned

Background

Around 816,000 new lung cancer cases were diagnosed in China in 2020, accounting for almost 18 percent of all the 4.6 million new cancer cases in China.

First of all we need to see @CizzlePlc as a company *with tremendous potentials. what Conduit pharmaceutical done is hard to understand because we just don't know their circumstances.

this is what I genuinely feel

"we are potentially on a cusp of something big"

thats all matters now,
sellers out, that's history, looking to the future deals, which can land anytime

First of all we need to see @CizzlePlc as a companion with tremendous potentials. what Conduit pharmaceutical done is hard to understand because we just don't know their circumstances.

this is what I genuinely feel

"we are potentially on a cusp of something big"

thats all matters now,
sellers out, that's history, looking to the future deals, which can land anytime

how will Simec pay the debts?

guys this stock is on the verge of going under, unless they can repay or restructure the debts.

debts is the issue for not the progress of deployment of turbines under the sea.

hope I made my point crystal clear

just in the UK around 50,000 and have Lung cancer patients each year.

say the per test costs around £100, that's 50,000 tests = £5M for per tests. however I think 2 tests will be minimum, and 4 tests per year.

This my perception of the UK market on Lung Cancer early detection from @CizzlePlc

50,000 X 4 tests (£100, per test) 2020 = £20M

then add USA, China, Europe, Asia, etc

just in the UK around 50,000 and have Lung cancer patients each year.

say the per test costs around £100, then that's 50,000 tests = £5M one one tests. the however I think 2 tests will be minimum, and 4 tests per year.

This my perception of the UK market on Lung Cancer early detection from @CizzlePlc

50,000 X 4 tests (£100, per test) 2020 = £20M

then add USA, China, Europe, Asia, etc

Over 46,000 people were diagnosed with lung cancer in the UK in 2015. An estimated 89% of lung cancers are preventable"

Early Detection is the key here, will save NHS hundreds of millions minimum.

"Over 46,000 people were diagnosed with lung cancer in the UK in 2015. An estimated 89% of lung cancers are preventable

Should see good news now, and sellers out, volume will take this pass 4p.

China deal worth hundreds of millions to Cizzle-Biotech alone.

thinking whether to Take a plunge.

Waiting for MTPH (Midatech Pharma) to announce good news.

GLA

How is this company not able to produce Audit account?
what could possibly go wrong?

could see news drop next week or so

conference last day.

https://informaconnect.com/bioeurope-spring/

ticking up on Nasdaq

4%

thats positive